menu toggle
English
English
Français
Contact Us
About Us
Who We Are
Our Leadership Team
Corporate Citizenship
Pharma & BioPharma
Commercialization Services
Digital Health Solutions
Corporate Wellness Programs
Patients and Healthcare Providers
InnomarPharmacy
InnomarClinics
Services
Our Integrated Model
3PL and Importation
Regulatory Services
Consulting Services
Patient Support Programs
Clinics and Nursing
Pharmacovigilance
Specialty Distribution
Pharmacy
Careers
Careers
Life at Innomar
Apply Today
The Cencora Network
Insights
News and Events
Find a Clinic or Pharmacy
English
English
Français
Contact Us
LinkedIn
About Us
Who We Are
Our Leadership Team
Corporate Citizenship
Pharma & BioPharma
Commercialization Services
Digital Health Solutions
Corporate Wellness Programs
Patients and Healthcare Providers
InnomarPharmacy
InnomarClinics
Services
Our Integrated Model
3PL and Importation
Regulatory Services
Consulting Services
Patient Support Programs
Clinics and Nursing
Pharmacovigilance
Specialty Distribution
Pharmacy
Careers
Careers
Life at Innomar
Apply Today
The Cencora Network
Insights
News and Events
Find a Clinic or Pharmacy
Contact Us
LinkedIn
Insights
Filter By
All Topics
Advocacy
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
Data
Distribution
Engagement
Legislation
Market access
Medication adherence
Medication therapy management
Oncology
Our role in healthcare
Patient care
Patient support services
Policy
Product access
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Third-party logistics
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
Innomar Strategies
Webinar on-demand - A Panel Discussion on Navigating Medical Devices in Canada
Innomar Strategies
July 2024
Manufacturers
Drug development checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
Pre-launch checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
Post launch checklist: what to look for in a commercialization partner
Innomar Strategies
April 2024
Manufacturers
InnomarLive 2023: Part One
Innomar Strategies
April 2023
Manufacturers
InnomarLive 2023: Part Two
Innomar Strategies
April 2023
Manufacturers
InnomarLive 2023: Part Three
Innomar Strategies
April 2023
Manufacturers
Regulatory Services: Management and Control of Certified Product Information Document
Innomar Strategies
August 2022
Manufacturers
Webinar: Impact of COVID-19 on Patient Support Programs in Canada
Innomar Strategies
June 2021
Manufacturers
Case Study: A flexible solution for launching a new molecule in oncology
Innomar Strategies
April 2021
Manufacturers
Case Study: Launching a new molecule for a rare disease
Innomar Strategies
April 2021
Manufacturers
Case Study: A proven approach for an emerging specialty pharma company
Innomar Strategies
April 2021
Manufacturers
The value of Real-World Evidence in Canadian drug commercialization: Part 2
Innomar Strategies
April 2021
Manufacturers
Webinar: Utilizing Real World Evidence Across the Product Life Cycle
Innomar Strategies
June 2020
Manufacturers
Regulatory Services: Submission Filing
Anne Tomalin
Quality, Regulatory & Safety
May 2020
Manufacturers
Regulatory Services: Submission and Product Lifecycle Considerations
Anne Tomalin
Quality, Regulatory & Safety
May 2020
Manufacturers
Regulatory Services: How are products approved?
Anne Tomalin
Quality, Regulatory & Safety
May 2020
Manufacturers
Regulatory Services: Navigating Clinical Trial applications
Anne Tomalin
Quality, Regulatory & Safety
May 2020
Manufacturers
Commercializing in Canada: Quality Assurance and GMP Services
Innomar Strategies
April 2020
Manufacturers
Commercializing in Canada: Regulatory Publishing and Submissions
Innomar Strategies
April 2020
Manufacturers
Webinar: Health Canada’s Regulatory and Quality approach to addressing COVID-19 challenges
Innomar Strategies
April 2020
Manufacturers
Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.
Sandra Anderson
Commercialization and Strategy
March 2020
Manufacturers
Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.
Sandra Anderson
Commercialization and Strategy
February 2020
Manufacturers
Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?
Sandra Anderson
Commercialization and Strategy
January 2020
Manufacturers
InnomarLive 2019: Commercializing in Canada
Innomar Strategies
December 2019
Explore More by Topic
Advocacy
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
